The laboratory mouse represents an important model for the study of phenylalanine metabolism and the pathochemistry of phenylketonuria, yet mouse phenylalanine hydroxylase (PAH) has not been extensively studied. We report the cloning and sequencing of a mouse PAH cDNA, the expression of enzymic activity from the mouse PAH cDNA clone and the identification of mouse PAH and human PAH by two-dimensional PAGE of liver samples. These data confirm the expected homology of mouse PAH and human PAH and suggest differences in the primary sequence and the phosphorylation state of the two enzymes.
INTRODUCTION
Phenylalanine hydroxylase (PAH, EC 1.14.16.1) has been the object of intensive biochemical investigation ever since Jervis [1] demonstrated that phenylalanine hydroxylation is an essential step in phenylalanine degradation and that this pathway is deficient in phenylketonuria. Rat PAH has been purified by several laboratories and characterized in detail [2] [3] [4] [5] . Human PAH has been subject to less intensive study, but, nevertheless, it has also been purified and its essential biochemical properties have been described [6] [7] [8] [9] [10] [11] . Many inferences about normal and pathological phenylalanine metabolism in humans arise from studies in rodents [12] [13] [14] . The cloning and sequencing of rat PAH [5, 15, 16] and human PAH [17, 18] has demonstrated that these enzymes are highly homologous [18, 19] .
The laboratory mouse is an increasingly important medium for the study of PAH. Mice treated with pharmacological inhibitors of PAH are used to study the pathophysiology of hyperphenylalaninaemia [20, 21] , and mutagenesis of mice with ethylnitrosourea has been used to generate an animal model of hyperphenylalaninaemia [22, 23] . Nevertheless, mouse PAH has never been purified, and there are few published data describing its properties.
In the present paper we describe cloning and sequencing of a full-length mouse PAH cDNA, comparison of the primary structure of mouse, human, and rat PAHs and constitution of mouse PAH activity in cultured cells. These experiments provide a structural and methodological foundation for characterization of mouse PAH and consideration of the laboratory mouse as a model for human hyperphenylalaninaemia.
MATERIALS AND METHODS Cloning and sequencing of mouse PAH cDNA Polyadenylated RNA was prepared from C57B/6J-mouse livers by using the guanidinium thiocyanate method [24] and affinity purification on oligo(dT)-cellulose. cDNAs were sizeselected over a sucrose gradient after first-strand synthesis for cDNA > I kb, and a library of 600000 independent recombinants was constructed in bacteriophage Agtl 1 by using modifications of the method of Young & Davis [25] . The library was probed with the human PAH cDNA (phPAH247) [18] nicktranslated to a specific radioactivity of 3 x 108 c.p.m./,ug with
[32P]dCTP (Amersham), and positive bacteriophages were plaque-purified by secondary and tertiary screening.
The EcoRI cDNA insert from the longest clone (moPAH8) was subcloned into M13mpl8. Terminal deletions were introduced by ExollI digestion [26] , and the sequence of overlapping terminally deleted subclones in both orientations was determined by the dideoxy chain-termination method of Sanger et al. [27] . This analysis made use of the Protein Identification Resource of the National Biomedical Research Foundation including the programs COMPARE, PRPLOT and CHOFAS.
DNA-mediated gene transfer
The mouse PAH cDNA was cloned into the vector pCEXV [28] , which contains the simian virus 40 origin of replication and early-region promoter. A construction containing human PAH cDNA in the vector 91023B [29] has been described previously [30] . These expression constructs were introduced into Cos cells [31 ] by calcium phosphate co-precipitation [32] . Cells [3, 11] . The reaction is stopped by incubation in boiling water for 5 min, then in ice fOr 5 Immunoreactive PAH was identified by Western blotting with affinity-purified goat anti-(rat PAH) antibody [5] and 125I-labelled pig anti-(goat IgG) antibody after SDS/PAGE and electrophoretic transfer to nitrocellulose paper as described by Johnson et al. [33] .
Two-dimensional PAGE
The methods used for electrophoresis were those described by O'Farrell [34] as modified by Anderson & Anderson [35, 36] . The exact conditions used were those outlined by Dunbar [37] . Liver fragments were homogenized in a solubilization buffer containing 9 M-urea (Bio-Rad Laboratories), 4 % (w/v) Nonidet P-40 (Accurate Chemical Co.), 2 % (v/v) Ampholines (LKB; 2: 1 ratio of pH 3.5-10 and pH 4-6) and 2 % (v/v) 2-mercaptoethanol (BioRad Laboratories) for 2 h at 25 'C. Samples were centrifuged at 200000 g for 2 h in a Beckman ultracentrifuge (Ti-60 rotor), and 20,l samples were focused with the use of a 3: 1 ratio of pH 3.5-10 and pH 4-6 Ampholines for 12000 V-h in the ISOapparatus (Health Products). Second-dimension electrophoresis was carried out in 10-20% polyacrylamide slab gels cast by using the DALT casing apparatus (Health Products) as described by Dunbar [37] . Duplicate gels were stained or electrophoretically transferred to nitrocellulose paper. The silver-based colour stain was used to detect proteins [37] . PAH was identified by probing transfer with goat anti-(rat PAH) antibody and 125I-labelled pig anti-(goat IgG) antibody as described above.
RESULTS

Cloning and sequencing of mouse PAH
Ten PAH clones were identified in the mouse liver library. The longest cDNA insert (moPAH8) was subcloned and sequenced in its entirety. A simplified restriction map relative to that of the human PAH cDNA is shown in Fig. 1 transitions being much less common. The nucleic acid sequences of mouse PAH and rat PAH cDNAs [16] show substantial similarity both within the open reading frame and untranslated regions (results not shown).
The sequence (Fig. 2 ) of mouse PAH is similar to those of human PAH [28] and rat PAH [16] (Fig. 3) . Mouse PAH is the same length as rat PAH, which is one amino acid residue longer than the human protein. There are only ten amino acid differences between rat PAH and mouse PAH, most of which are conservative. There are 36 differences between the human and mouse sequences. Six of the differences occur in the first 12 amino acids, and two-thirds of the differences occur among the first 115 amino acids at the N-terminal end. One striking difference between the human and rodent sequences is the reciprocal substitution of serine for cysteine at position 29 and of cysteine for isoleucine at position 373, which preserves the number of cysteine residues (nine).
Expression of recombinant mouse PAH and human PAH in cultured cells
The human PAH cDNA has previously been expressed in Cos cells using the expression vector 91023B [29, 30] . (Fig. 4c, lane 4) . No immunoreactive material was present in Cos cells transformed with pCEXV as a control (Fig. 4c, lane 5) . MetAlaAlaValValLeuGluAsnGlyValLeuSerArgLysLeuSerAspPheGlvlnGluThrSerTyrIle  5' ATTCACCCTGTGCTAGCTAGACACCTCACTTACTGAGAGCCAGCATGGCAGCTGTTGTCCTGGAGACGGAGTCCTGAGCAGAAAACTCTCAGACTGGGCAGGAACAGTTACA 3   10  20  30  40  50  60  70  80  90  100  110  120   GluAspAsnSerAsnGlnAsnGlyAlaValSerLeuIlePheSerLeuLysGluGluValGlyAlaLeuAlaLysValLeuArgLeuPheGluGluAsnGluIleAsnLeuThrHisIle   5' TCGAGACACTCCATCAAATGGTGCTGTATCTCTGATATTCTCACTCAAGAGGAAGTTGGTGCCCTGGCCMGGTCCTGCGCTTATGAGGAGATGAGATCACCTGACACACA 3  130  140  150  160  170  180  190  200  210  220  230  240   GluSerArgProSerArgLeuAsnLysAspGluTyrGluPhePheThrTyrLeuAspLysArgSerLysProValLeuGlySerIleIleLysSerLeuArgAsnAspIleGlyAlaThr   5' TTGATCCAGACCTTCCCG AACAAGATGAGTATGAGTTTCACCTATCTGGATMGCGTAGCAAGCCCGTCCTGGGCAGCATCATCAGAGCCTGAGGACGACATTGGTGCCA 3  250  260  270  280  290  300  310  320  330  340  350 [38, 39] .
Identification of PAH by two-dimensional PAGE Duplicate two-dimensional gels of mouse liver and human liver were prepared for silver staining and Western blotting. A single spot of immunoreactive material was present in human liver, and two adjacent spots were present in mouse liver (results not shown). These spots superimposed with prominent yellowstaining spots indicated by arrows in tri-colour silver stained gels of mouse liver (Fig. 5a ), human liver (Fig. Sb) or a mixture of mouse and human livers (Fig. Sc) .
DISCUSSION
These experiments describe the cloning and sequencing of a biologically active mouse PAH cDNA. Mouse PAH exhibits little sequence divergence from rat PAH. It also exhibits profound similarity to human PAH, differing at only 36 of 452 amino acid residues. Nevertheless, these studies show several potentially significant differences between mouse PAH and human PAH.
First, most of the differences in the amino acid sequences are clustered within the first N-terminal 115 residues. This region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an 'inhibitory' domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule [19, 40] . Biochemical studies demonstrate that a 35 kDa proteolytic fragment of rat PAH produced by cleaving 11 kDa from the N-terminus and 5 kDa from the Cterminus retains complete catalytic activity [40] . There Kwok et, al. [18] . The rat sequence is from Dahl et al. [16] . The position of the phosphorylated serine residue in rat PAH is indicated [38] .
are statistically uncommon [41] and because alterations in the topology of the disulphide bonds can potentially alter structure-function determinants. In particular, it has been shown that there are five free thiol groups in rat PAH and that thiolgroup modification alters the activation state of the rat enzyme [42] . There are no data indicating which cysteine residues may be involved in this modification.
Thirdly, two-dimensional PAGE analysis reveals two immunoreactive spots of mouse PAH but only one spot of human PAH. The presence of two immunoreactive PAH species noted previously in the rat has been a source of historical controversy. The presence of two bands was initially interpreted as indicative of two physically distinct subunits comprising the PAH multimer. Subsequent studies indicated that the active PAH apoenzyme was constituted from a single gene [43] and that the two bands represented phosphorylated and dephosphorylated forms of PAH protein (reviewed in ref. [6] ). Although similar studies have not yet been performed with mouse PAH, it is likely that the two species in mouse liver represent phosphorylated and dephosphorylated forms. Allelic heterogeneity has been observed by PAGE or two-dimensional PAGE in several species [44, 45] . The present work was performed in inbred mice in which all loci are presumed to be homozygous; therefore it is unlikely that the two bands observed in the mouse represent allelic heterogeneity.
There remains considerable uncertainty about whether human PAH is a phosphoprotein. Several studies have failed to demonstrate phosphorylation of the human enzyme [10] . Our finding of a single immunoreactive species in human livers by two-dimensional PAGE is consistent with these data. Other studies have suggested that there are multiple species of human PAH on two-dimensional PAGE [46] and that a monoclonal antibody can be raised specifically against the [15] [16] [17] [18] has the probability, whereas in human PAH the 3-turn a the highest calculated probability.
, Human PAH.
form of human PAH [47] . In the present worn the multiple forms of human PAH observ [46, 47] .
The position of the phosphorylated serine the Chou-Fasman algorithm indicates that, although the sequence in the vicinity of amino acid residues 15-18 encompassing the phosphorylation site would be predicted to be a fl-turn in both proteins, the human protein has an even higher potential for fl-turn in the vicinity of amino acid residues 8-11 encompassing Pro-9 (Fig. 6a) . Thus the sequences that could theoretically constitute the substrate for the protein kinase in the human sequence may have an altered topology relative to the rat and mouse sequences and might be less susceptible to phosphorylation. Previous studies in rats and mice demonstrate that rodents have an order of magnitude greater phenylalanine-hydroxylating 400 500 activity in their livers than humans. The explanation for this difference remains unclear. In our experiments, more PAH S (Mouse) activity was found in mouse liver than in human liver (Fig. 4a) , lanes 13-26) and more activity was seen in Cos cells transfected with mouse PAH than in cells transfected with human PAH (Fig. 4b) . There was, however, also correspondingly more immunoreactive protein in the mouse liver and Cos cells transfected with mouse PAH (Fig. 4c ) and more protein apparent on Coomassie Blue-stained two-dimensional PAGE gels (results not shown), suggesting that the difference in activity might be reflective of the differential steady-state concentrations of the two enzymes in the cells rather than intrinsic differences in C (Human) apoenzyme structure and function. It is impossible to compare 30~quantitatively the specific activities of the two enzymes from 30 40 these data, since the anti-PAH antibody raised against rat PAH may not have equal affinity for mouse and human proteins and id human PAH these enzymes may not have equivalent stability in cellular an PAH and mouse extracts. This inference, however, is consistent with previous 18] were iteratively reports, particularly those by Gillam et al. [4] and Woo et al. [8] proximate positions indicating that purified rat PAH and human PAH have similar irrows. (b) Predicted specific activities ( Knax.). Quantitative determination of the a and human PAH. relative specific activities of mouse PAH and human PAH will ed over five residues need additional biochemical analysis and purification of these 'he differences in the enzymes. This process should be greatly expedited by the ability his region are noted, to express large amounts of active PAH in prokaryotes [11] .
the phosphorylation Differences in the activity and structure of human and rodent tions of potentialPAHs have important implications for the use of rodents as highest calculated models for hyperphenylalaninaemia. Differences in activity canit positions 8-1 has not be merely ascribed to an allometric association between PAH; ------, mouse organism size or metabolic rate. Such differences must ultimately be accounted for by differences in the rate of transcription, translation, stability, activation or intrinsic catalytic activity of the enzymes. The cloning of mouse PAH and constitution of PAH activity in cultured cells by gene transfer provide a means we did not observe for comparing the activity of mouse PAH and human PAH in red by Smith et al.
parallel and controlled experiments and may begin to address the applicability of the mouse as a model system for human residue in rat PAH hyperphenylalaninaemia. has been determined to be Ser-16 by isolation and sequencing of a fragment containing the phosphorylated group [38] . The presence of a homologous sequence that maintained the consensus Arg-Lys-Xaa-Ser motif in human PAH suggested that the human enzyme would be similarly phosphorylated [18] . The subsequent sequencing of full-length rat and mouse clones indicates that, although the central motif of the phosphorylation site is preserved, there are seven amino acid differences between the rodent and human sequences in the first 34 amino acids surrounding Ser- 16 . These include substitutions of Cys-29, Pro-9, Ser-2 and Thr-3 in the human sequence and Ser-29, Gly-9, Ala-2 and Ala-3 in the rodent sequence. The result of these substitutions is to make the N-terminal end of human PAH considerably more hydrophilic than those of rodent PAHs (Fig. 6) and to substitute relatively bulky amino acid residues for alamine and glycine. Analysis of potential fl-turn sites by using
